SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000928385-97-002017
Filing Date
1997-12-10
Accepted
1997-12-10 00:00:00
Documents
2
Group Members
CARLYLE-SEQUANA INVESTORS II, L.P.CARLYLE-SEQUANA INVESTORS L.L.C.TC GROUP LLCTCG HOLDINGS, L.L.C.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 21683
2 JOINT FILING AGREEMENT EX-99.A 2746
  Complete submission text file 0000928385-97-002017.txt   26645
Mailing Address C/O CARLYLE GROUP 1001 PENNSYLVANIA AVENUE NW SUITE 220 S WASHINGTON DC 20004
Business Address C/O THE CARLYLE GROUP 1001 PENNSYLVANIA AVENUE NW SUITE 220 S WASHINGTON DC 20004-2505 2023472626
TC GROUP LLC (Filed by) CIK: 0000933790 (see all company filings)

IRS No.: 527656007 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address
Business Address 11099 NORTH TORREY PINES RD SUITE 160 LA JOLLA CA 92037 6194526550
SEQUANA THERAPEUTICS INC (Subject) CIK: 0000946736 (see all company filings)

IRS No.: 330550509 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49547 | Film No.: 97735287
SIC: 2835 In Vitro & In Vivo Diagnostic Substances